Table 2.
Characteristics of the included studies
| Study | Study design | Patient enrollment | Number of patients | Number of lesions | Gender ratio (m:f) | Patient age: mean (range) | Cirrhosis | Child-pugh class A/B/C | Number of HCC lesions | Lesion size (cm) |
|---|---|---|---|---|---|---|---|---|---|---|
| Kakihara et al. | Retrospective | NDa | 15 | 118 | 11:4 | 55 (45–71) | Cirrhosis | 0/8/7 | 61 | 1.3 (0.5–6.6) |
| Nishie et al. | Retrospective | ND | 12 | 103 | 9:3 | 60 (46–72) | Cirrhosis | 0/6/6 | 26 | 1.2 (0.5–3.4) |
| Yoo et al. | Retrospective | Consecutive | 33 | 104 | 27:6 | 53.3 (46–60) | Cirrhosis | 46/16/5 | 82 | 2.25 (0.3–5.1) |
| Di Martino et al. | Prospective | Consecutive | 58 | 109 | 39:19 | 63 (35–84) | Cirrhosis | 30/21/7 | 87 | 1.8 (0.3–7.0) |
| Akai et al. | Prospective | Consecutive | 34 | CT: 74 MR: 97 |
27:7 | 65 (48–78) | Cirrhosis or not | ND | 52 | 2.6 (0.4–15.2) |
| Haradome et al. | Retrospective | Consecutive | 75 | 99 | 60:15 | 54.7 (42–67) | Cirrhosis or not | 48/5/1 | 60 | 1.74 (1.09–2.39) |
| Baek et al. | Retrospective | Consecutive | 51 | 111 | 43:5 | (32–80) | Cirrhosis | 42/7/2 | 73 | 2.98 (0.2–10) |
| Sun et al. | Retrospective | ND | 42 | CT: 61 MR: 60 |
56:13 | 56 (39–73) | Cirrhosis | ND | 33 | 1.37 (0.96–1.78) |
| Kim et al. | Retrospective | Consecutive | 62 | 132 | 54:8 | 55 (31–67) | Cirrhosis or not | 62/0/0 | 83 | 2.9 (0.5–10.5) |
| Sano et al. | Retrospective | Consecutive | 64 | CT: 248 MR: 253 |
47:17 | mb: 66 (56–75); fc: 71 (62–80) |
Cirrhosis or not | 54/10/0 | 96 | 1.27 (0.4–2) |
| Granito et al. | Prospective | Consecutive | 33 | 48 | 25:8 | 70 (48–74) | Cirrhosis | 28/5/0 | 38 | 1.8 (1.0–3.0) |
| Park et al. | Retrospective | Consecutive | 148 | 125 | 103:45 | 56 (30–73) | Cirrhosis | 141/5/2 | 102 | 1.3 (0.6–2.0) |
| Study | Blindd | CT or MRI read first | Time interval between MRI and CT reading | CT Scanner row | Magnetic field strength | Use pathology as the only reference standard | Gd-EOB-DTPA-enhanced MR imaging | Multidetector CT | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tph | Fpi | Fnj | Tnk | Tp | Fp | fn | tn | |||||||
| Kakihara et al. | Y | CT | 4 weeks | 64 | 1.5 T | Yes | 20 | 2 | 16 | 80 | 15 | 3 | 21 | 79 |
| Nishie et al. | Y | CT | 4 weeks | 64 | 3 T | Yes | 16 | 4 | 14 | 69 | 16 | 4 | 14 | 69 |
| Yoo et al. | Y | CT | ND | 64 | 3 T | Yes | 54 | 2 | 28 | 20 | 36 | 1 | 46 | 21 |
| Di Martino et al. | Ye | Random | NDg | 64 | 1.5 T | No | 74 | 1 | 13 | 21 | 60 | 5 | 27 | 17 |
| Akai et al. | Yf | Reader 1 CT, Reader 2 MR | >2 weeks | 64 | 1.5 T | Yes | 45 | 4 | 7 | 41 | 41 | 3 | 12 | 18 |
| Haradome et al. | Ye | CT | 3 weeks | 16 | 1.5 T | No | 52 | 3 | 8 | 36 | 42 | 2 | 18 | 37 |
| Baek et al. | Y | Random | ND | 64, 16, 4 | 3 T | No | 65 | 2 | 8 | 34 | 56 | 2 | 17 | 36 |
| Sun et al. | Y | MR | 2 weeks | 64, 16, 8 | 3 T | No | 30 | 2 | 3 | 25 | 18 | 1 | 15 | 27 |
| Kim et al. | Y | Random | 4 weeks | 64, 40, 16 | 3 T | Yes | 77 | 2 | 6 | 47 | 74 | 3 | 9 | 46 |
| Sano et al. | Y | Random | >1 weeks | 16 | 1.5 T | Yes | 87 | 8 | 4 | 154 | 58 | 3 | 29 | 158 |
| Granito et al. | Y | ND | ND | 6, 16 | 1.5 T | No | 38 | 3 | 0 | 7 | 22 | 0 | 16 | 10 |
| Park et al. | Y | CT | ND | 64, 40 | 3 T | No | 100 | 3 | 2 | 20 | 64 | 1 | 38 | 22 |
This table provides details of all the studies included in this research, from clinical information to imaging information
aNo data
bMale
cFemale
dImage readers were blinded to patient’s histories, laboratory results, findings of other imaging techniques, and final diagnosis
eImage readers were aware of patients’ history of cirrhosis and that patients had been suspected of HCC
fImage readers were aware that patients were suspected of HCC
gReading session interval (where MR and CT images were mixed in a random order in one session) > 4 weeks
hTrue positive. The number in this column refers to the number of true-positive lesions
iFalse positive. The number in this column refers to the number of false-positive lesions
jFalse negative. The number in this column refers to the number of false-negative lesions
kTrue negative. The number in this column refers to the number of true-negative lesions